The DOI matches its Crossref record; 35 of the 36 references it cites were found in a registry or an index.
Inflammatory Cytokine Concentrations Are Acutely Increased by Hyperglycemia in Humans: Role of Oxidative Stress
Abstract
Background— Circulating levels of interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α) are elevated in diabetic patients. We assessed the role of glucose in the regulation of circulating levels of IL-6, TNF-α, and interleukin-18 (IL-18) in subjects with normal or impaired glucose tolerance (IGT), as well as the effect of the antioxidant glutathione. Methods and Results— Plasma glucose levels were acutely raised in 20 control and 15 IGT subjects and maintained at 15 mmol/L for 5 hours while endogenous insulin secretion was blocked with octreotide. In control subjects, plasma IL-6, TNF-α, and IL-18 levels rose ( P <0.01) within 2 hours of the clamp and returned to basal values at 3 hours. In another study, the same subjects received 3 consecutive pulses of intravenous glucose (0.33 g/kg) separated by a 2-hour interval. Plasma cytokine levels obtained at 3, 4, and 5 hours were higher ( P <0.05) than the corresponding values obtained during the clamp. The IGT subjects had fasting plasma IL-6 and TNF-α levels higher ( P <0.05) than those of control subjects. The increase in plasma cytokine levels during the clamping lasted longer (4 hours versus 2 hours, P <0.01) in the IGT subjects than in the control subjects, and the cytokine peaks of IGT subjects after the first glucose pulse were higher ( P <0.05) than those of control subjects. On another occasion, 10 control and 8 IGT subjects received the same glucose pulses as above during an infusion of glutathione; plasma cytokine levels did not show any significant change from baseline after the 3 glucose pulses. Conclusions— Hyperglycemia acutely increases circulating cytokine concentrations by an oxidative mechanism, and this effect is more pronounced in subjects with IGT. This suggests a causal role for hyperglycemia in the immune activation of diabetes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Similarly, a negative influence of postprandial hypertriglyceridemia on endothelial function has been reported in both normal and diabetic subjects.”
In the citing paper
“Other studies have demonstrated that fluctuations in blood glucose levels may contribute more to outcomes than constant high blood glucose concentrations.31–35”
From Increased Time in Range and Fewer Missed Bolus Injections After Introduction of a Smart Connected Insulin Pen (2020) · cites this paper as [32]
Citations
Cites
C-Reactive Protein, Interleukin 6, and Risk of Developing Type 2 Diabetes Mellitus
Pradhan, A. D. (2001) · JAMA · doi:10.1001/jama.286.3.327 · Cited by 4,433
Ridker, P. M., Rifai, N., Stampfer, M. J., & Hennekens, C. H. (2000) · Circulation · doi:10.1161/01.cir.101.15.1767 · Cited by 2,429
Capes, S. E., Hunt, D., Malmberg, K., & Gerstein, H. C. (2000) · The Lancet · doi:10.1016/s0140-6736(99)08415-9 · Cited by 2,187
Subcutaneous Adipose Tissue Releases Interleukin-6, But Not Tumor Necrosis Factor-α,in Vivo1
Mohamed‐Ali, V., Goodrick, S., Rawesh, A., Katz, D. R., Miles, J. M., Yudkin, J. S., Klein, S., & Coppack, S. W. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.12.4450 · Cited by 2,032
Oxidative Stress and Diabetic Vascular Complications
Giugliano, D., Ceriello, A., & Paolisso, G. (1996) · Diabetes Care · doi:10.2337/diacare.19.3.257 · Cited by 1,921
Self-citationYuan, M., Konstantopoulos, N., Lee, J., Hansen, L., Li, Z.-W., Karin, M., & Shoelson, S. E. (2001) · Science · doi:10.1126/science.1061620 · Cited by 1,884
Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly
Harris, T. B., Ferrucci, L., Tracy, R. P., Corti, M. C., Wacholder, S., Ettinger, W. H., Heimovitz, H., Cohen, H. J., & Wallace, R. (1999) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)00066-2 · Cited by 1,488
Pickup, J. C., Mattock, M. B., Chusney, G. D., & Burt, D. J. (1997) · Diabetologia · doi:10.1007/s001250050822 · Cited by 1,246
Ridker, P. M., Rifai, N., Pfeffer, M., Sacks, F., Lepage, S., & Braunwald, E. (2000) · Circulation · doi:10.1161/01.cir.101.18.2149 · Cited by 934
Activation of Receptor for Advanced Glycation End Products
Schmidt, A. M., Yan, S. D., Wautier, J., & Stern, D. M. (1999) · Circulation Research · doi:10.1161/01.res.84.5.489 · Cited by 799
Cited by
Sorted by citations
Items 501–600 of 1,003
Mason, R. H., Minaker, S. A., Luna, G. M. L., Bapat, P., Farahvash, A., Garg, A., Bhambra, N., & Muni, R. H. (2022) · Eye · doi:10.1038/s41433-022-02127-x · Cited by 59
Al-Waili, N., Salom, K., Al-Ghamdi, A., Ansari, M. J., Al-Waili, A. N., & Al-Waili, T. N. (2013) · Journal of Medicinal Food · doi:10.1089/jmf.2012.0285 · Cited by 54
“Hyperglycemia increases circulatory cytokine concentrations by an oxidative mechanism, particularly in subjects with impaired glucose tolerance.(67) Table 3 summarizes studies conducted on patients with type 1 and type 2 diabetes.”
Hyperglycemia and Acute Coronary Syndrome
DEEDWANIA, P. C., Kosiborod, M., Barrett, E. J., Ceriello, A., Isley, W. L., Mazzone, T., & Raskin, P. (2008) · Anesthesiology · doi:10.1097/aln.0b013e31817dced3 · Cited by 55
“Both in vitro and in vivo studies have linked hyperglycemia with elevated levels of C-reactive protein, interleukin-6, and tumor necrosis factor- .(45,46) Tumor necrosis factor- has been shown to extend infarct size in laboratory animals and to induce myocardiocyte apoptosis.”
BackgroundSelf-citationAltınova, A. E., Yetkin, İ., Akbay, E., Bukan, N. C., & Arslan, M. (2008) · Cytokine · doi:10.1016/j.cyto.2008.02.006 · Cited by 54
Garcia, F. A. D. O., Rebouças, J. F., Balbino, T. Q., da Silva, T. G., de Carvalho-Júnior, C. H. R., Cerqueira, G. S., Brito, G. A. D. C., & Viana, G. S. D. B. (2015) · Journal of Inflammation · doi:10.1186/s12950-015-0080-5 · Cited by 57
Blood Glucose, Diet-Based Glycemic Load and Cognitive Aging Among Dementia-Free Older Adults
Seetharaman, S., Andel, R., McEvoy, C. L., Aslan, A. K. D., Finkel, D., & Pedersen, N. L. (2014) · The Journals of Gerontology Series A · doi:10.1093/gerona/glu135 · Cited by 54
The Endocrine System during Sepsis
Brierre, S., deBoisblanc, B. P., & Kumari, R. (2004) · The American Journal of the Medical Sciences · doi:10.1097/00000441-200410000-00007 · Cited by 52
Hjort, A., Iggman, D., & Rosqvist, F. (2024) · Clinical Nutrition · doi:10.1016/j.clnu.2024.02.014 · Cited by 55
Increased expression of IL-18 in the serum and islets of type 1 diabetics
Harms, R. Z., Yarde, D. N., Guinn, Z. P., Lorenzo-Arteaga, K. M., Corley, K. P., Cabrera, M. S., & Sarvetnick, N. (2015) · Molecular Immunology · doi:10.1016/j.molimm.2014.12.012 · Cited by 54
“Furthermore, perturbations of IL-18 are also associated with dyslipidemia, hypertension and insulin resistance [33], and Esposito's group found that acutely inducing hyperglycemia in human subjects significantly increases circulating IL-18 levels [56].”
BackgroundFatani, A. J., Al-Rejaie, S. S., Abuohashish, H. M., Alassaf, A. M., Parmar, M., & Ahmed, M. M. (2015) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-015-0693-5 · Cited by 56
“This elevation was abolished by supplementation of the antioxidants suggesting that hyperglycemia-induced cytokine production may be mediated by ROS [12].”
BackgroundInfluentialPersistent Hyperglycemia Is Associated With Increased Mortality After Intracerebral Hemorrhage
Wu, T. Y., Jukka Putaala, A., Sharma, G. J., Strbian, D., Tatlisumak, T., Davis, S. M., & Meretoja, A. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.117.005760 · Cited by 53
“state.(33) Further, there is evidence of progressive increase in perihematomal glucose metabolism in human ICH peaking at day 3, likely in response to increased perihematomal inflammatory cell infiltrate.”
A Critical Evaluation of Wet Biomarkers for Huntington’s Disease: Current Status and Ways Forward
Silajdžić, E., & Björkqvist, M. (2018) · Journal of Huntington s Disease · doi:10.3233/jhd-170273 · Cited by 56
Jang, J., Moon, S., Cho, S., Cho, K. H., & Oh, C. (2019) · Scientific Reports · doi:10.1038/s41598-018-37834-7 · Cited by 54
Јovanović, J. A., Mihailović, M., Bogojević, D., Ivanović‐Matić, S., Uskoković, A. S., Poznanović, G., & Grigorov, I. (2012) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-012-0186-7 · Cited by 53
Hayashi, T., Sohmiya, K., Ukimura, A., Endoh, S., Mori, T., Shimomura, H., Okabe, M., Terasaki, F., & Kitaura, Y. (2003) · Heart · doi:10.1136/heart.89.10.1236 · Cited by 53
Izci-Balserak, B., & Pien, G. W. (2014) · Current Diabetes Reports · doi:10.1007/s11892-013-0459-8 · Cited by 52
Prattichizzo, F., de Candia, P., Nicolucci, A., & Ceriello, A. (2021) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3476 · Cited by 54
Self-citationMatos‐Souza, J. R., de Oliveira, R. T. D., Blotta, M. H. S. L., & Coelho, O. R. (2008) · Arquivos Brasileiros de Cardiologia · doi:10.1590/s0066-782x2008000200004 · Cited by 52
Tran, B., Oliver, S. R., Rosa, J. S., & Galassetti, P. (2012) · International Journal of Experimental Diabetes Research · doi:10.1155/2012/683680 · Cited by 57
“Hyperglycemia is known to induce an acute state of inflammation, both in healthy and in diabetic subjects [15].”
BackgroundKim, J. A., Lee, J. S., Chung, H. S., Roh, E., Lee, Y.-B., Hong, S.-H., Kim, N. H., Yoo, H. J., Seo, J. A., Kim, S. G., et al. (2018) · Diabetes Care · doi:10.2337/dc18-0802 · Cited by 52
“Acute hyperglycemia increases circulating inflammatory cytokines through an oxidative mechanism in humans, and this effect is more prominent in individuals with impaired glucose tolerance (23).”
BackgroundAcute hyperglycaemia induces an inflammatory response in young patients with type 1 diabetes
Gordin, D., Forsblom, C. M., Rönnback, M., Parkkonen, M., Wadén, J., Hietala, K., & Groop, P. (2008) · Annals of Medicine · doi:10.1080/07853890802126547 · Cited by 52
C-Reactive Protein Levels Following Acute Myocardial Infarction
Wong, V., McLean, M. P., BOYAGES, S. C., & Cheung, N. W. (2004) · Diabetes Care · doi:10.2337/diacare.27.12.2971 · Cited by 52
“Acute hyperglycemia is proinflammatory, inducing the release of cytokines by an oxidative mechanism, resulting in neutrophil-mediated injury of the reperfused myocardium (1,5).”
BackgroundZhang, D., Li, N., Xi, Y., Zhao, Y., & Wang, T. (2017) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2017.04.005 · Cited by 50
Hami, J. (2015) · World Journal of Diabetes · doi:10.4239/wjd.v6.i3.412 · Cited by 51
Antioxidant and inflammatory response following high-fat meal consumption in overweight subjects
Miglio, C., Peluso, I., Raguzzini, A., Villaño, D., Cesqui, E., Catasta, G., Toti, E., & Serafini, M. (2012) · European Journal of Nutrition · doi:10.1007/s00394-012-0420-7 · Cited by 54
“The link between acute fat over-ingestion and vascular impairment involves the generation of excess free radicals, leading to postprandial oxidative stress [7, 8] and the release into the circulation of C.”
BackgroundDual drug-loaded nanoparticles on self-integrated scaffold for controlled delivery
Kim, S., Bennet, Marimuthu, M., & An (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s32800 · Cited by 51
“7,8 The mechanisms of acceleration of oxidative stress should be evaluated for development of multimodal treatment options in diabetic populations.”
Ceriello, A. (2010) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1097/01.hjr.0000368193.24732.66 · Cited by 52
Self-citationNaidoo, V., Naidoo, M., & Ghai, M. (2018) · Scandinavian Journal of Immunology · doi:10.1111/sji.12723 · Cited by 51
“Furthermore, hyperglycaemia has been found to cause dysregulation of innate immune system responses, thus increasing production levels of circulating inflammatory proteins called cytokines that can lead to chronic inflammation in T2DM.(6) Recent studies have also suggested that the interaction between environmental (l…”
BackgroundQi, L., Rifai, N., & Hu, F. B. (2007) · Diabetes · doi:10.2337/db07-0505 · Cited by 51
“Diabetes, as a disorder of hyperglycemia, can induce inflammatory response, especially through overproduction of reactive oxygen species (40,41).”
BackgroundThe impact of glycemic variability on diabetic peripheral neuropathy
Jin, H. Y., Lee, K. A., & Park, T. S. (2016) · Endocrine · doi:10.1007/s12020-016-1005-7 · Cited by 49
“Among these, acute fluctuations or wide ranges of glucose levels may worsen pathogenic mediators to a greater extent than sustained hyperglycemia with respect to inflammatory cytokines and oxidative stresses [16, 17, 31, 32].”
Potential Benefits of Antioxidant Phytochemicals in Type 2 Diabetes
Arabshomali, A., Bazzazzadehgan, S., Mahdi, F., & Shariat‐Madar, Z. (2023) · Molecules · doi:10.3390/molecules28207209 · Cited by 56
Kim, H., Shin, J.-A., Lee, S., Kim, E.-S., Cho, J., Son, H., & Yoon, K. (2013) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2013.0038 · Cited by 50
Hyperosmotic stress enhances cytokine production and decreases phagocytosis in vitro
Otto, N., Schindler, R., Lun, A., Boenisch, O., Frei, U. A., & Oppert, M. (2008) · Critical Care · doi:10.1186/cc6989 · Cited by 51
“Hyperglycemia enhances plasma levels of interleukin (IL)-6 and tumor necrosis factor-alpha (TNF-α) in normal healthy volunteers [7,8].”
BackgroundGeisler, T., Mueller, K., Aichele, S., Bigalke, B., Stellos, K., Htun, P., Ninci, E., Fateh-Moghadam, S., May, A. E., & Gawaz, M. (2010) · Clinical Research in Cardiology · doi:10.1007/s00392-010-0179-x · Cited by 50
“Hyperglycemia activates inflammatory cytokines [ 17 ].”
Reddy, A. B. M., Ramana, K. V., Srivastava, S., Bhatnagar, A., & Sk, S. (2008) · Endocrinology · doi:10.1210/en.2008-0677 · Cited by 50
Energetic stress: The reciprocal relationship between energy availability and the stress response
Harrell, C. S., Gillespie, C. F., & Neigh, G. N. (2015) · Physiology & Behavior · doi:10.1016/j.physbeh.2015.10.009 · Cited by 51
“A uthor M anuscript A uthor M anuscript A uthor M anuscript A uthor M anuscript associated with proinflammatory outcomes and increases plasma cytokines (Esposito et al., 2002), hypoglycemia can also impact the stress response through its effects on inflammatory mediators.”
Gunnett, C. A., Heistad, D. D., & Faraci, F. M. (2003) · Stroke · doi:10.1161/01.str.0000099123.55171.3f · Cited by 49
Cosentino, F., & Assenza, G. E. (2004) · Herz · doi:10.1007/s00059-004-2635-8 · Cited by 51
“There is also evidence that glucose intake induces acute oxidative stress and inflammation at the cellular and molecular level [ 34 ].”
BackgroundMalin, S. K., Kirwan, J. P., Sia, C. L., & González, F. (2015) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00510.2014 · Cited by 49
Metabolic Factors, Adipose Tissue, and Plasminogen Activator Inhibitor-1 Levels in Type 2 Diabetes
Belalcazar, L. M., Ballantyne, C. M., Lang, W., Haffner, S. M., Rushing, J., Schwenke, D. C., Pi-Sunyer, X., & Tracy, R. P. (2011) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.111.224386 · Cited by 48
Brignardello, E., Runzo, C., Aragno, M., Catalano, M. G., Cassader, M., Perin, P. C., & Boccuzzi, G. (2007) · Diabetes Care · doi:10.2337/dc07-1110 · Cited by 49
Clinical Need for Continuous Glucose Monitoring in the Hospital
Joseph, J. I., Hipszer, B. R., Mraović, B., Chervoneva, I., Joseph, M., & Grunwald, Z. (2009) · Journal of Diabetes Science and Technology · doi:10.1177/193229680900300611 · Cited by 51
Pinto, M. D. S., Kwon, Y., Apostolidis, E., Lajolo, F. M., Genovese, M. I., & Shetty, K. (2010) · Journal of Food Biochemistry · doi:10.1111/j.1745-4514.2009.00305.x · Cited by 49
Yoo, S., Lee, H., Lee, H., & Ryu, H. G. (2016) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000001632 · Cited by 49
Effects of Berberine chloride on the liver of streptozotocin-induced diabetes in albino Wistar rats
Chandirasegaran, G., Elanchezhiyan, C., & Ghosh, K. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.01.007 · Cited by 49
Role of Hippocampal Lipocalin-2 in Experimental Diabetic Encephalopathy
Bhusal, A., Rahman, M. H., Lee, I., & Suk, K. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00025 · Cited by 48
Telomeres and atherosclerosis : review article
Khan, S., Chuturgoon, A. A., & Naidoo, D. P. (2012) · Cardiovascular journal of South Africa/Cardiovascular journal of Southern Africa · doi:10.5830/cvja-2012-056 · Cited by 48
Childhood trauma, the stress response and metabolic syndrome: A focus on DNA methylation
Womersley, J. S., Nöthling, J., Toikumo, S., Malan‐Müller, S., van den Heuvel, L. L., McGregor, N. W., Seedat, S., & Hemmings, S. M. J. (2021) · European Journal of Neuroscience · doi:10.1111/ejn.15370 · Cited by 52
“Furthermore, hyperglycaemia that can occur due to glucocorticoid receptor-induced insulin resistance is also associated with inflammation, including increased levels of TNF-α and IL-6 (Aljada et al., 2006; Esposito et al., 2002).”
BackgroundIs Hyperglycemia a Causal Factor in Cardiovascular Disease?
Davidson, J. A., & Parkin, C. G. (2009) · Diabetes Care · doi:10.2337/dc09-s333 · Cited by 52
Inflammation in Metabolic Syndrome and Type 2 Diabetes: Impact of Dietary Glucose
KEMPF, K., ROSE, B., HERDER, C., KLEOPHAS, U., MARTIN, S., & KOLB, H. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1372.012 · Cited by 48
Zhang, X., Zhang, R., Cheng, L., Wang, Y., Ding, X., Fu, J., Dang, J., Moore, J., & Li, R. (2020) · Sleep Medicine · doi:10.1016/j.sleep.2020.05.014 · Cited by 50
Kim, S. O., PARK, J. Y., Jeon, S. Y., YANG, C. H., & Kim, M.-R. (2015) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2015.2093 · Cited by 48
Sickle, B. J. V., Simmons, J. H., Hall, R. T., Raines, M., Ness, K., & Spagnoli, A. (2009) · Cytokine · doi:10.1016/j.cyto.2009.08.011 · Cited by 48
Diabetes mellitus and gastric emptying: questions and issues in clinical practice
Samsom, M., Bharucha, A. E., Gerich, J. E., Herrmann, K., Limmer, J., Linke, R., Maggs, D. G., Schirra, J. R. J., Vella, A. V., Wörle, H., et al. (2009) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.974 · Cited by 49
Erectile Hydraulics: Maximizing Inflow While Minimizing Outflow
Meldrum, D. R., Burnett, A. L. “., Dorey, G., Esposito, K., & Ignarro, L. J. (2014) · The Journal of Sexual Medicine · doi:10.1111/jsm.12457 · Cited by 47
Self-citationLorencio, C., Leal, Y., Bonet, A., Bondía, J., Palerm, C. C., Taché, A., Sirvent, J.-M., & Vehı́, J. (2012) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2012.0008 · Cited by 49
“5 [6–10]).”
Hao, Y., Lu, Q., Li, T., Yang, G., Hu, P., & Ma, A. (2017) · BMC Cardiovascular Disorders · doi:10.1186/s12872-016-0441-x · Cited by 49
Akasaka, T., Sueta, D., Tabata, N., Takashio, S., Yamamoto, E., Izumiya, Y., Tsujita, K., Kojima, S., Kaikita, K., Matsui, K., et al. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.116.004841 · Cited by 48
“By increasing advanced glycosylation end product levels and protein kinase C activation and attenuating superoxide dismutase glycosylation, hyperglycemia increases oxidative stress, exacerbates insulin resistance, causes chronic inflammation, and impedes vascular endothelial function, ultimately increasing the likelih…”
BackgroundA highly sensitive immunoassay for interleukin‐6 in dried blood spots
Miller, E. M., & McDade, T. W. (2012) · American Journal of Human Biology · doi:10.1002/ajhb.22324 · Cited by 47
Hyperglycaemia and neurological injury
Prakash, A., & MATTA, B. F. (2008) · Current Opinion in Anaesthesiology · doi:10.1097/aco.0b013e32830f44e4 · Cited by 47
Development of aldose reductase inhibitors for the treatment of inflammatory disorders
Chatzopoulou, M., Pegklidou, K., Papastavrou, N., & Demopoulos, V. J. (2013) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2013.843524 · Cited by 48
“[41] showed that acute hyperglycemia increases circulating cytokines (TNF-a, IL-6 and IL-18), which have been implicated in insulin resistance, plaque destabilization (IL-18) and future cardiovascular events (IL-6).”
BackgroundCardiovascular Benefits of Exogenous Insulin
Chaudhuri, A., Dandona, P., & Fonseca, V. A. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1112 · Cited by 49
Matuschik, L., Riabov, V., Schmuttermaier, C., Sevastyanova, T. N., Weiß, C., Klüter, H., & Kzhyshkowska, J. G. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031385 · Cited by 48
Nutritional State and COPD: Effects on Dyspnoea and Exercise Tolerance
Tramontano, A., & Palange, P. (2023) · Nutrients · doi:10.3390/nu15071786 · Cited by 47
Insulin resistance in diabetic nephropathy — cause or consequence?
Svensson, M. K. E., & Eriksson, J. W. (2006) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.648 · Cited by 47
“promote IR in CRF and ESRD [110,125,126].”
Jia, H., Aw, W., Egashira, K., Takahashi, S., Aoyama, S., Saito, K., Kishimoto, Y., & Kato, H. (2014) · Genes & Nutrition · doi:10.1007/s12263-014-0389-3 · Cited by 47
“Chronic over-nutrition leading to obesity (Esposito 2002; Mohanty et al. 2000) has resulted”
Jian-wei, Z., He, L., Cao, S., Yang, Q., Yang, S., & Zhou, Y. (2014) · Diabetology & Metabolic Syndrome · doi:10.1186/1758-5996-6-76 · Cited by 48
“Physiological studies have suggested several mechanisms through which GV may adversely impact prognosis in the setting of AMI, including oxidative stress [4], cytokine release [5], and endothelial dysfunction [6].”
BackgroundBuchan, L. J., Aubin, C. R. S., Fisher, A., Hellings, A., Castro, M. J., Al‐Nakkash, L., Broderick, T. L., & Plochocki, J. H. (2018) · BMC Research Notes · doi:10.1186/s13104-018-3862-z · Cited by 47
Maiti, R., Agrawal, N. K., Dash, D., & Pandey, B. L. (2007) · Vascular Pharmacology · doi:10.1016/j.vph.2007.05.004 · Cited by 47
Parenteral iron compounds sensitize mice to injury-initiated TNF-α mRNA production and TNF-α release
Zager, R. A., Johnson, A. C. M., Hanson, S. Y., & Lund, S. (2004) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00342.2004 · Cited by 47
“For example, redox-sensitive transcription factors, most notably NF- B, cFos, c-Jun, activator protein 1, and hypoxia-inducible factor-1 , are upregulated by oxidative stress (9, 13, 25, 35, 44).”
BackgroundGu, M., Mordwinkin, N. M., Kooreman, N. G., Lee, J., Wu, H., Hu, S., Churko, J. M., Diecke, S., Burridge, P. W., He, C., et al. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu411 · Cited by 46
Kiyici, S. K., Ersoy, C., Kaderlï, A. A., Fazlıoğlu, M., Budak, F., Duran, C., Gül, Ö. Ö., Sığırlı, D., Baran, İ., Tuncel, E., et al. (2009) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2009.07.004 · Cited by 46
The association of metabolic syndrome markers with adhesive capsulitis
Austin, D. C., Gans, I., Park, M. J., Carey, J. L., & Kelly, J. D. A. (2014) · Journal of Shoulder and Elbow Surgery · doi:10.1016/j.jse.2013.11.004 · Cited by 47
Scopoletin Supplementation Ameliorates Steatosis and Inflammation in Diabetic Mice
Choi, R., Ham, J. R., Lee, H.-I., Cho, H. W., Choi, M., Park, S., Lee, J., Kim, M., Seo, K., & Lee, M. (2017) · Phytotherapy Research · doi:10.1002/ptr.5925 · Cited by 46
Carlsson, A. C., Ruge, T., Kjøller, E., Hilden, J., Kolmos, H. J., Sajadieh, A., Kastrup, J., Jensen, G. B., Larsson, A. O., Nowak, C., et al. (2018) · Journal of the American Heart Association · doi:10.1161/jaha.117.008299 · Cited by 46
“Third, hyperglycemia and diabetes mellitus are common in patients with coronary heart disease and have been shown to affect the levels of oxidative stress.(31,32) Oxidative stress increases the overall TNF-a system activity(31) and has been shown to be associated with TNFR2,(33) which showed the highest risk estimates…”
BackgroundSteroid use during COVID-19 infection and hyperglycemia – What a physician should know
Sosale, A., Sosale, B., Kesavadev, J., Chawla, M. S., Reddy, S., Saboo, B., & Misra, A. (2021) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2021.06.004 · Cited by 46
Powell, L. A., Warpeha, K. M., Xu, W., Walker, B., & Trimble, E. R. (2004) · Journal of Molecular Endocrinology · doi:10.1677/jme.1.01671 · Cited by 46
“Inflammatory cytokines are also increased in diabetes (Esposito et al. 2002).”
BackgroundTimmer, J. R. (2006) · QJM · doi:10.1093/qjmed/hcl028 · Cited by 46
“Elevated glucose levels induce an increase in inflammatory markers in healthy people, and hyperglycaemic patients with an acute myocardial infarction have an augmented inflammatory response compared to normoglycaemic patients.(29,30) Intensive glycometabolic intervention may decrease the negative effects of hyperglyca…”
Coyle, Y. M. (2008) · Methods in molecular biology · doi:10.1007/978-1-60327-492-0_2 · Cited by 45
Ramana, K. V., Tammali, R., Reddy, A. B. M., Bhatnagar, A., & Sk, S. (2007) · Endocrinology · doi:10.1210/en.2007-0512 · Cited by 45
Interleukin 6 Function in the Skin and Isolated Keratinocytes Is Modulated by Hyperglycemia
Lee, E. G., Luckett‐Chastain, L. R., Calhoun, K. N., Frempah, B., Bastian, A., & Gallucci, R. M. (2019) · Journal of Immunology Research · doi:10.1155/2019/5087847 · Cited by 45
Luzio, R. D., Dusi, R., Mazzotti, A., Petroni, M. L., Marchesini, G., & Bianchi, G. P. (2020) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s225796 · Cited by 49
Ganesan, K., Ramkumar, K. M., & Xu, B. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173606 · Cited by 47
RetractedAdegoke, E. O., Rahman, M. S., Park, Y., Kim, Y. J., & Pang, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22083939 · Cited by 47
“Further, IR results in elevated circulating glucose levels, which in turn worsens the generation of oxidative stress [46], and type 2 diabetes and vascular disease”
BackgroundHigher Stress Hyperglycemia Ratio Is Associated With a Higher Risk of Stroke-Associated Pneumonia
Tao, J., Hu, Z., Lou, F., Wu, J., Wu, Z., Yang, S., Jiang, X., Wang, M., Huang, Q., & Ren, W. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.784114 · Cited by 45
Luo, J., Xu, S., Li, H., Li, Z., Gong, M., Qin, X., Zhang, X., Hao, C., Liu, X., Zhang, W., et al. (2022) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2022.07.004 · Cited by 47
Semeraro, F., Cancarini, A., Morescalchi, F., Romano, M. R., dell’Omo, R., Ruggeri, G., Agnifili, L., & Costagliola, C. (2014) · Diabetes & Metabolism · doi:10.1016/j.diabet.2014.04.005 · Cited by 44
“[5] Esposito K, Nappo F, Marfella R, Giugliano G, Giugliano F, Ciotola M, et al.”
BackgroundInfluentialLi, J., Wu, F. Y., Zhang, H., Fu, F., Ji, L., Dong, L., Li, Q., Liu, W., Zhang, Y., Lv, A., et al. (2009) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2009.07.010 · Cited by 44
“Other than that, hyperglycemia is reported to increase generation of reactive oxygen species whichmay promote inflammation [25] so it is possible that prevention of glucose toxicity and promotion of glucose utilization may also contribute to the benefits of insulin in MI/R.”
BackgroundStress Hyperglycemia, Inflammation, and Cardiovascular Events
Esposito, K., Marfella, R., & Giugliano, D. (2003) · Diabetes Care · doi:10.2337/diacare.26.5.1650-a · Cited by 45
Self-citationNakamura, T., Ako, J., Kadowaki, T., Funayama, H., Sugawara, Y., Kubo, N., & Momomura, S. (2009) · Journal of Cardiology · doi:10.1016/j.jjcc.2008.11.011 · Cited by 44
Glucose Variability and Mortality in Patients Hospitalized With Acute Myocardial Infarction
Lipska, K. J., Venkitachalam, L., GOSCH, K. L., Kovatchev, B. P., den Berghe, G. V., Meyfroidt, G., Jones, P. G., Inzucchi, S. E., Spertus, J. A., DeVries, J. H., et al. (2012) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.111.963298 · Cited by 44
Prentice, J. C., Pizer, S. D., & Conlin, P. R. (2016) · Diabetic Medicine · doi:10.1111/dme.13166 · Cited by 44
Liu, C., Hsu, T., Chen, K., Tan, Y.-P., Lii, C., & Sheen, L. (2012) · Journal of Traditional and Complementary Medicine · doi:10.1016/s2225-4110(16)30087-6 · Cited by 44
“…have been observed in the plasma of persons with uncontrolled diabetes and of healthy volunteers who underwent a hyperglycemic clamp procedure (Esposito et al., 2002), and in isolated human monocytes challenged with a high concentration of glucose (Shanmugam et al., 2003; Shanmugam et al.,…”
BackgroundInfluentialChen, I.-J., Chang, K. C., Lou, Y.-M., Wu, W., & Özçakar, L. (2019) · Journal of Neurology · doi:10.1007/s00415-019-09254-8 · Cited by 45
Yu, J. H., Han, K., Park, S. H., Lee, D. Y., Nam, G. E., Seo, J. A., Kim, S. G., Baik, S. H., Park, Y. G., Kim, S. M., et al. (2019) · Medicine · doi:10.1097/md.0000000000016317 · Cited by 44
“Use of an antioxidant prevents this effect.([26]) Second, repeated glycemic fluctuation increases inflammatory cytokines and macrophage adhesion to endothelial cells,([26,27]) which are involved in atherosclerosis progression.”
BackgroundAnti-Inflammatory Effects of Insulin and the Pro-Inflammatory Effects of Glucose
Dandona, P., Chaudhuri, A., Ghanim, H., & Mohanty, P. (2006) · Seminars in Thoracic and Cardiovascular Surgery · doi:10.1053/j.semtcvs.2006.06.003 · Cited by 46
Koskenkari, J. K., Kaukoranta, P. K., Rimpiläinen, J., Vainionpää, V., Ohtonen, P. P., Surcel, H., Juvonen, T. S., & Ala-Kokko, T. I. (2006) · Acta Anaesthesiologica Scandinavica · doi:10.1111/j.1399-6576.2006.01100.x · Cited by 44
“Hyperglycemia has been shown to raise the levels of inflammatory markers including cytokines and CRP, both in healthy subjects (16) and in patients with acute myocardial infarction (17).”
BackgroundSatoh, N., Shimatsu, A., Yamada, K., Aizawa-Abe, M., Suganami, T., Kuzuya, H., & Ogawa, Y. (2006) · Metabolism · doi:10.1016/j.metabol.2006.01.016 · Cited by 32
“Systemic inflammation and oxidative stress have been postulated to be important pathogenic factors in the development of the metabolic syndrome and thus atherosclerosis [2].”
BackgroundAmabile, N., Jacquier, A., Shuhab, A., Gaudart, J., Bartoli, J., Paganelli, F. F., & Moulin, G. (2011) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.23278 · Cited by 44
“Hyperglycemia can induce acute coronary endothelial dysfunction [22,23], decrease myocardial preconditioning [24], enhance oxidative stress [25] and proinflammatory cytokines release within infarcted myocardium [25] and activate coagulation [26].”
BackgroundThe metabolic syndrome sensitizes leukocytes for glucose-induced immune gene expression
Kempf, K., Rose, B., Herder, C., Haastert, B., Fusbahn-Laufenburg, A., Reifferscheid, A., Scherbaum, W. A., Kolb, H., & Martin, S. (2006) · Journal of Molecular Medicine · doi:10.1007/s00109-006-0132-7 · Cited by 45
“Nevertheless, in NGT subjects, plasma levels normalized within 2–3 h, while in obese, IGT, or T2DM subjects, glucose-induced inflammation was stronger or lasted longer [10, 11].”
Background
Metadata
- Authors
- Esposito, K., Nappo, F., Marfella, R., Giugliano, G., Giugliano, F., Ciotola, M., Quagliaro, L., Ceriello, A., & Giugliano, D.
- Affiliations
- University of Udine (IT)
- Venue
- Circulation
- Published
- 2002-10-15
- Volume
- 106
- Issue
- 16
- Pages
- 2067-2072
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2123560318
- Cited by
- 1,961
- References
- 36
- Citations by year
- 2026: 57 · 2025: 69 · 2024: 88 · 2023: 95 · 2022: 106 · 2021: 91 · 2020: 102 · 2019: 83 · 2018: 86 · 2017: 70 · 2016: 87 · 2015: 112 · 2014: 99 · 2013: 102 · 2012: 101
- FWCI
- 38.18
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Circulation (publishedVersion)
- PubMed (publishedVersion)
- Institutional Research Information System (University of Udine) (submittedVersion)
- Archivio Istituzionale della Ricerca - Università degli Studi della Campania "Luigi Vanvitelli" (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- hyperglycemia, inflammatory cytokines, interleukin-6, TNF-α, IL-18, impaired glucose tolerance, glutathione, oxidative stress, glucose clamp
- MeSH terms
- Adult, Antioxidants, Blood Glucose, Diabetes Mellitus, Type 2, Female, Glucose Tolerance Test, Glutathione, Humans, Inflammation, Kinetics, Male, Tumor Necrosis Factor-alpha, Interleukin-6, Cytokines, Glucose Intolerance, Oxidative Stress, Interleukin-18
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review